Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.
about
Fixed-dose combination therapy for the prevention of cardiovascular diseaseCombining antihypertensive and antihyperlipidemic agents - optimizing cardiovascular risk factor managementCost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)Assessing patterns of use of cardio-protective polypill component medicines in Australian women.Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.Amlodipine + atorvastatin single pill is the most effective choice for primary prevention.Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model.Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy.Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases.
P2860
Q24195065-BEB54BB1-076B-4463-A8FC-1E6BB5F4FAE8Q35602493-0DBEED75-35DD-40E9-877B-CC63445830EBQ36810011-D876968B-0FC6-4113-A18C-BCA002E3C1A2Q39478333-90B9BF67-BEED-4474-9FA0-D2C93D3B4546Q41187803-BD4D8C03-460F-49C1-9550-8E4F04298B6CQ41659292-39341E46-BE3A-4FF9-B785-A97274BCC32FQ43491750-E0B603DD-5080-41B1-B421-F33FAAE8D8D2Q44514737-FA0DF8B2-1F6C-4D9E-8A48-D28235380CB1Q47599452-96875E45-08BD-4B65-875E-AB2DD56313C5Q47889719-730F5255-0675-493D-8B71-F2BD2930071BQ51019364-0A1050A1-5CE3-4ED4-8F3F-E9184FFEA251
P2860
Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association between adherence ...... ong US managed care enrollees.
@ast
Association between adherence ...... ong US managed care enrollees.
@en
type
label
Association between adherence ...... ong US managed care enrollees.
@ast
Association between adherence ...... ong US managed care enrollees.
@en
prefLabel
Association between adherence ...... ong US managed care enrollees.
@ast
Association between adherence ...... ong US managed care enrollees.
@en
P2093
P2860
P356
P1476
Association between adherence ...... ong US managed care enrollees.
@en
P2093
Craig S Roberts
Jason Yeaw
Richard H Chapman
P2860
P2888
P356
10.1186/1471-2261-10-29
P577
2010-06-17T00:00:00Z
P5875
P6179
1002292783